GR1000074B - Lipoid vesicula for endoperitoneal supplying of therapeutical elements - Google Patents
Lipoid vesicula for endoperitoneal supplying of therapeutical elementsInfo
- Publication number
- GR1000074B GR1000074B GR880100233A GR880100233A GR1000074B GR 1000074 B GR1000074 B GR 1000074B GR 880100233 A GR880100233 A GR 880100233A GR 880100233 A GR880100233 A GR 880100233A GR 1000074 B GR1000074 B GR 1000074B
- Authority
- GR
- Greece
- Prior art keywords
- vesicula
- endoperitoneal
- lipoid
- therapeutical
- supplying
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/829—Liposomes, e.g. encapsulation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Steroid Compounds (AREA)
Abstract
Περιγράφονται λιποσωματικά κυστίδια ενδεικνυόμενα για την ενίσχυση της παροχής θεραπευτικών παραγόντων στην περιτοναϊκή κοιλότητα, και μέθοδοι παρασκευής και χρήσεώς τους. ωDescribed are liposomal vesicles indicated for enhancing the delivery of therapeutic agents to the peritoneal cavity, and methods of their preparation and use. oh
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/035,065 US4877619A (en) | 1986-08-25 | 1987-04-06 | Liposomal vesicles for intraperitoneal administration of therapeutic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
GR880100233A GR880100233A (en) | 1989-01-31 |
GR1000074B true GR1000074B (en) | 1990-10-31 |
Family
ID=21880417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR880100233A GR1000074B (en) | 1987-04-06 | 1988-04-06 | Lipoid vesicula for endoperitoneal supplying of therapeutical elements |
Country Status (7)
Country | Link |
---|---|
US (1) | US4877619A (en) |
EP (1) | EP0345302A4 (en) |
JP (1) | JPH02502907A (en) |
AU (1) | AU1590988A (en) |
CA (1) | CA1320443C (en) |
GR (1) | GR1000074B (en) |
WO (1) | WO1988007853A1 (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5910489A (en) * | 1990-09-18 | 1999-06-08 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
US5990096A (en) * | 1990-09-18 | 1999-11-23 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
CA2061703C (en) * | 1992-02-20 | 2002-07-02 | Rudolf E. Falk | Formulations containing hyaluronic acid |
US5824658A (en) * | 1990-09-18 | 1998-10-20 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
CA2099588C (en) * | 1990-12-03 | 2003-04-15 | Larry J. Moore | Prevention of synovial adhesions |
US5977088A (en) * | 1991-07-03 | 1999-11-02 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US5792753A (en) * | 1991-07-03 | 1998-08-11 | Hyal Pharmaceutical Corporation | Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs |
US6103704A (en) * | 1991-07-03 | 2000-08-15 | Hyal Pharmaceutical Corporation | Therapeutic methods using hyaluronic acid |
US6218373B1 (en) | 1992-02-20 | 2001-04-17 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US5767106A (en) * | 1992-02-21 | 1998-06-16 | Hyal Pharmaceutical Corporation | Treatment of disease and conditions associated with macrophage infiltration |
US6806084B1 (en) * | 1992-06-04 | 2004-10-19 | The Regents Of The University Of California | Methods for compositions for in vivo gene delivery |
US6004534A (en) * | 1993-07-23 | 1999-12-21 | Massachusetts Institute Of Technology | Targeted polymerized liposomes for improved drug delivery |
WO1995003035A1 (en) * | 1993-07-23 | 1995-02-02 | Massachusetts Institute Of Technology | Polymerized liposomes with enhanced stability for oral delivery |
US5746223A (en) * | 1996-10-11 | 1998-05-05 | Williams; Kevin Jon | Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis |
US5997899A (en) * | 1996-10-01 | 1999-12-07 | Skyepharma Inc. | Method for producing liposomes with increased percent of compound encapsulated |
US6060082A (en) | 1997-04-18 | 2000-05-09 | Massachusetts Institute Of Technology | Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery |
IL135060A (en) * | 1997-09-18 | 2005-12-18 | Skyepharma Inc | Sustained release liposomal anesthetic compositions and methods for the preparation thereof |
EP1030652B1 (en) | 1997-11-14 | 2012-04-25 | Pacira Pharmaceuticals, Inc. | Production of multivesicular liposomes |
DE69940735D1 (en) | 1998-07-17 | 2009-05-28 | Pacira Pharmaceuticals Inc | BIODEGRADABLE ARRANGEMENTS FOR THE CONTROLLED RELEASE OF INCLUDED SUBSTANCES |
US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
US7473433B2 (en) | 2000-12-21 | 2009-01-06 | Nektar Therapeutics | Pulmonary delivery of polyene antifungal agents |
ATE508363T1 (en) * | 2000-12-06 | 2011-05-15 | Ecole Polytech | METHOD FOR PRODUCING A BIOANALYTICAL REAGENT, DETECTION METHOD BASED ON THE USE OF THE BIOANALYTICAL REAGENT, AND THE USE THEREOF |
WO2002072016A2 (en) * | 2001-03-13 | 2002-09-19 | Wayne State University | Method of preventing adhesions with ifn-¿y? |
EP1395243A2 (en) * | 2001-05-31 | 2004-03-10 | SkyePharma Inc. | Encapsulation of nanosuspensions in liposomes and microspheres |
GB0200704D0 (en) * | 2002-01-14 | 2002-02-27 | Britannia Pharmaceuticals Ltd | Use of phospholipids in peritoneal dialysis |
US20030235610A1 (en) * | 2002-06-21 | 2003-12-25 | Piedmont Pharmaceuticals, Llc | Liposomes containing biologically active compounds |
US8795627B2 (en) | 2007-03-21 | 2014-08-05 | Raptor Pharmaceuticals Inc. | Treatment of liver disorders by administration of RAP conjugates |
ES2330295B1 (en) * | 2008-06-06 | 2010-09-23 | Laboratorios Alcala Farma, Sl | TOPIC FORMULATION OF IBUPROFEN. |
US20110250266A1 (en) | 2008-10-07 | 2011-10-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Liposomal systems comprising sphingomyelin |
JP5476013B2 (en) * | 2009-03-27 | 2014-04-23 | 株式会社ファンケル | Topical skin preparation |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
US10610486B2 (en) | 2010-10-28 | 2020-04-07 | Pacira Pharmaceuticals, Inc. | Sustained release formulation of a non-steroidal anti-inflammatory drug |
US10596117B1 (en) | 2014-12-31 | 2020-03-24 | Eric Morrison | Lipoleosomes as carriers for aromatic amide anesthetic compounds |
US11007161B1 (en) | 2014-12-31 | 2021-05-18 | Eric Morrison | Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films |
US10561627B2 (en) | 2014-12-31 | 2020-02-18 | Eric Morrison | Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films |
EP3440187A1 (en) * | 2016-04-07 | 2019-02-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Francisella lipids as broad anti-inflammatory therapeutics and associated methods of use |
EP3541815A4 (en) | 2016-11-18 | 2020-07-15 | Pacira Pharmaceuticals, Inc. | Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same |
US11357727B1 (en) | 2021-01-22 | 2022-06-14 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
US11278494B1 (en) | 2021-01-22 | 2022-03-22 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
US11033495B1 (en) | 2021-01-22 | 2021-06-15 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3992513A (en) * | 1975-01-07 | 1976-11-16 | Atomic Energy Of Canada Limited | Labelled phospholipid material colloidially dispersed and sized to localize at preselected organs |
GB1523965A (en) * | 1976-03-19 | 1978-09-06 | Ici Ltd | Pharmaceutical compositions containing steroids |
DE2914788A1 (en) * | 1979-04-11 | 1980-10-16 | Nattermann A & Cie | PARENTERAL APPLICABLE, STABLE DRUG SOLUTIONS WITH ANTI-INFLAMMATORY EFFECT |
US4522803A (en) * | 1983-02-04 | 1985-06-11 | The Liposome Company, Inc. | Stable plurilamellar vesicles, their preparation and use |
US4708861A (en) * | 1984-02-15 | 1987-11-24 | The Liposome Company, Inc. | Liposome-gel compositions |
US4619795A (en) * | 1984-12-24 | 1986-10-28 | Technicon Instruments Corp. | Method for preparing lipid vesicles |
AU587299B2 (en) * | 1985-11-27 | 1989-08-10 | Ethicon Inc. | Method for inhibiting post-surgical adhesion formation by the topical administration of non-steroidal anti- inflammatory drug |
-
1987
- 1987-04-06 US US07/035,065 patent/US4877619A/en not_active Expired - Lifetime
-
1988
- 1988-04-06 EP EP19880903666 patent/EP0345302A4/en not_active Withdrawn
- 1988-04-06 CA CA000563359A patent/CA1320443C/en not_active Expired - Fee Related
- 1988-04-06 AU AU15909/88A patent/AU1590988A/en not_active Abandoned
- 1988-04-06 WO PCT/US1988/001015 patent/WO1988007853A1/en not_active Application Discontinuation
- 1988-04-06 JP JP63503421A patent/JPH02502907A/en active Pending
- 1988-04-06 GR GR880100233A patent/GR1000074B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1988007853A1 (en) | 1988-10-20 |
JPH02502907A (en) | 1990-09-13 |
CA1320443C (en) | 1993-07-20 |
US4877619A (en) | 1989-10-31 |
AU1590988A (en) | 1988-11-04 |
GR880100233A (en) | 1989-01-31 |
EP0345302A4 (en) | 1990-02-20 |
EP0345302A1 (en) | 1989-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR1000074B (en) | Lipoid vesicula for endoperitoneal supplying of therapeutical elements | |
AU587232B2 (en) | Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles and methods for using same for tumor therapy | |
DE69505677D1 (en) | LIPOSOMAL ADMINISTRATION SYSTEM FOR BIOLOGICALLY ACTIVE SUBSTANCES | |
DK472980A (en) | LIPID VEHICLE AND METHOD OF PRODUCING THEREOF | |
FI924918A0 (en) | ANORDINATION FOR THE CONSTRUCTION OF IONTOFORETISK ADMINISTRATION AV ETT CEILINGS | |
DK582487D0 (en) | SMALL PARTICULARS AEROSOLLIPOSOM AND LIPOSOM MEDICINAL COMBINATIONS FOR MEDICAL USE | |
IT8547939A1 (en) | LIPOSOMES CONTAINING INTERLEUCINE METHOD FOR THEIR PREPARATION AND THEIR THERAPEUTIC USE IN CANCER DISEASES | |
NO884154L (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PREPARATIONS. | |
HUP0002521A2 (en) | Onium salts of paclitaxel, process for producing them and medicaments comprising the same | |
GR1000490B (en) | Preparation method of 4-ammonium derivatives of epipodophyllotoxinc glucosite | |
NZ503568A (en) | Biphasic lipid vesicle composition for transdermal administration of an immunogen | |
EP0335133A3 (en) | Drug delivery using pulmonary surfactant fo facilitate absorption | |
DK360188D0 (en) | MEDICINE DELIVERY BODY | |
KR950700725A (en) | Liposomal composition (LIPOSOME COMPOSITION) | |
HU907959D0 (en) | Medical preparations | |
GR1000419B (en) | Dosage form for acalcium antagonist supply | |
ATE110959T1 (en) | LIPOSOME DELIVERY SYSTEM FOR OPOID ANALGESICS. | |
MX9304133A (en) | NEW DERIVATIVES OF PHOSPHOLIPIDS. | |
EP0389570A4 (en) | High integrity liposomes and method of preration and use | |
MY114218A (en) | The use of bambuterol or a pharmaceutically acceptable salt thereof, to make lipid lowering pharmaceutical preparations. | |
EP0301449A3 (en) | Enantiomers of propafenone-containing therapeutic agents | |
ES8600055A1 (en) | A procedure for co-encapsulating a liposome-drug preparation in lipid vesicles |